Quantcast
Last updated on April 18, 2014 at 0:13 EDT

Latest Heart valve Stories

2013-11-13 08:28:46

TSX Venture Exchange: NVC VANCOUVER, Nov. 13, 2013 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that the first patent covering the company's innovative Tiara(TM) transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office. The new patent protects key aspects of the Tiara mitral valve prosthesis. It is the first patent to issue from a portfolio of US and international patent applications Neovasc has filed aimed at...

2013-11-06 23:02:04

Dr. Stewart Appointed Director of Aortic Surgery and Co-Director of the Valve Center in the Department of Cardiothoracic Surgery at Icahn School of Medicine at Mount Sinai New York, NY (PRWEB) November 06, 2013 The Mount Sinai Hospital is pleased to announce leading cardiac surgeon, Allan S. Stewart, MD, has been appointed Director of Aortic Surgery and Co-Director of the Valve Center in the Department of Cardiothoracic Surgery. Dr. Stewart joins Mount Sinai from NewYork-Presbyterian...

2013-11-05 11:53:57

Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery. First results from the trial were announced at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco. Results were positive, with high survival rates and low rates of stroke. “This is a major breakthrough,” said Fred Leya, MD, co-principal investigator at the Loyola...

2013-11-05 08:37:03

INCLINE VILLAGE, Nev., Nov. 5, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has entered into a debt financing transaction with Direct Flow Medical, Inc. (DFM), a transcatheter heart valve innovator focused on improving patient outcomes. PDL will provide a total of up to $50 million to DFM to be used to refinance its existing credit facility and fund the commercialization of its transcatheter aortic valve system used to treat aortic...

2013-10-31 20:21:52

New Data Announced At TCT 2013 Demonstrate Successful Deployment In All 120 Patients With No Severe Paravalvular Regurgitation At 30 Days San Francisco, Oct. 31, 2013 /PRNewswire/ -- The Boston Scientific Corporation (NYSE: BSX) Lotus(TM) Valve System met a key performance measure in the treatment of symptomatic patients with severe aortic valve stenosis considered at high risk for surgical valve replacement, according to new data released today at the Transcatheter Cardiovascular...

2013-10-30 23:00:13

DeZURIK, Inc. has received GOST certification, in cooperation with SVPRK in Moscow, that allows sales of its complete product line into the Russian Federation. Sartell, MN (PRWEB) October 31, 2013 DeZURIK, Inc. has received its GOST certification that allows sales of its complete product line into the Russian Federation. The certification was achieved in cooperation with DeZURIK’s newly appointed sales representative SVPRK, headquartered in Moscow, Russia. The GOST Certificate,...

2013-10-30 20:24:51

Results Show Treatment Provides Clinical Benefits and Improves Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk ABBOTT PARK, Ill., Oct. 30, 2013 /PRNewswire/ -- Abbott today announced clinically meaningful changes to quality of life, a reduction in rehospitalization for heart failure, and functional improvements for patients treated with the company's first-in-class, catheter-based MitraClip(®) therapy for patients with degenerative...

2013-10-29 08:31:53

--Preclinical Studies Show Innovative Transcatheter Product to Treat Mitral Regurgitation is Safe, Technically Feasible and Results in a Well-Functioning Mitral Bioprosthesis- --Sets Stage for First-in-Human Implantations Targeted for Early 2014-- TSX Venture Exchange: NVC VANCOUVER, Oct. 29, 2013 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that a review of results from preclinical studies of its Tiara(TM)( )valve for the transcatheter treatment of mitral...

2013-10-28 04:20:55

MUNICH and PALO ALTO, California, October 28, 2013 /PRNewswire/ -- BioMedPartners and Edwards LifeSciences Join Series A in Second Closing Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M. Additional Series A investors include BioMedInvest II LP and...

2013-10-25 23:00:22

The Washington University and Barnes-Jewish Heart & Vascular Center was one of 47 centers nationwide to participate in the medical trial that led to approval of the device by the FDA. St. Louis (PRWEB) October 25, 2013 A device approved today by the Federal Drug Administration (FDA) to treat leaky mitral valves was first used in this region as part of a clinical trial at the Washington University and Barnes-Jewish Heart & Vascular Center. This new non-surgical alternative for...


Latest Heart valve Reference Libraries

Heart
2013-01-01 11:25:12

The heart is a part of the circulatory system, and is considered one of the most vital organs of the human body. It is about the size of a fist, has a mass of approximately 300 grams, and its main function is to contract and produce enough pressure to circulate blood throughout the body. The top of the heart where the veins and arteries all connect is called the base. The pointed lower tip of the heart is called the apex. The coronary sulcus is a deep groove that runs horizontally across the...

More Articles (1 articles) »